{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:19:22Z","timestamp":1790119162440,"version":"4.0.1"},"reference-count":34,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Neurodegener. Dis. Manag."],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.2217\/nmt-2022-0032","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T09:42:12Z","timestamp":1688031732000},"page":"223-234","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Glatiramer Acetate Or IFN-\u03b2 Bridging Therapy in Women With Relapsing Multiple Sclerosis Planning a Pregnancy"],"prefix":"10.1080","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-9011","authenticated-orcid":false,"given":"Kerstin","family":"Hellwig","sequence":"first","affiliation":[{"name":"Department of Neurology St Josef Hospital Katholisches Klinikum Bochum gGmbH Ruhr University Bochum\rGudrunstrasse 56\rBochum\r44791\rGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Thiel","sequence":"additional","affiliation":[{"name":"Department of Neurology St Josef Hospital Katholisches Klinikum Bochum gGmbH Ruhr University Bochum\rGudrunstrasse 56\rBochum\r44791\rGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Haben","sequence":"additional","affiliation":[{"name":"Department of Neurology St Josef Hospital Katholisches Klinikum Bochum gGmbH Ruhr University Bochum\rGudrunstrasse 56\rBochum\r44791\rGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea I","family":"Ciplea","sequence":"additional","affiliation":[{"name":"Department of Neurology St Josef Hospital Katholisches Klinikum Bochum gGmbH Ruhr University Bochum\rGudrunstrasse 56\rBochum\r44791\rGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kurzeja","sequence":"additional","affiliation":[{"name":"European Medical Affairs Teva Pharmaceuticals Europe B.V.\rAmsterdam\rThe Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0562-7"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000922"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.05.005"},{"key":"e_1_3_6_7_1","unstructured":"European Medicines Agency . Dimethyl fumarate (Tecfidera\u00ae). Summary of product characteristics (2018). www.ema.europa.eu\/en\/documents\/product-information\/tecfidera-epar-product-information_en.pdf"},{"key":"e_1_3_6_8_1","unstructured":"European Medicines Agency . Terflunomide (Aubagio\u00ae). Summary of product characteristics (2018). www.ema.europa.eu\/en\/documents\/product-information\/aubagio-epar-product-information_en.pdf"},{"key":"e_1_3_6_9_1","unstructured":"European Medicines Agency . Fingolimod (Gilenya\u00ae). Summary of product characteristics (2021). www.ema.europa.eu\/en\/documents\/product-information\/gilenya-epar-product-information_en.pdf"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211051012"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.06.007"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.08.1048"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09450-6"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518816614"},{"issue":"10","key":"e_1_3_6_15_1","first-page":"e832","article-title":"Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: maternal risks","volume":"90","author":"Portaccio E","year":"2018","unstructured":"Portaccio E , MoiolaL, MartinelliVet al. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: maternal risks. Neurology, 90(10), e832\u2013e839 (2018).","journal-title":"Neurology"},{"key":"e_1_3_6_16_1","unstructured":"Electronic Medicines Compendium . Glatiramer acetate (Copaxone\u00ae) Summary of product characteristics (2022). www.medicines.org.uk\/emc\/product\/7046\/smpc#gref"},{"key":"e_1_3_6_17_1","unstructured":"European Medicines Agency . Interferon (Rebif\u00ae). Summary of product characteristics (2021). www.ema.europa.eu\/en\/documents\/product-information\/rebif-epar-product-information_en.pdf"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000327"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1145-x"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.697974"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211054956"},{"key":"e_1_3_6_22_1","unstructured":"European Medicines Agency . Natalizumab (Tysabri\u00ae). Summary of product characteristics (2016). www.ema.europa.eu\/en\/documents\/product-information\/tysabri-epar-product-information_en.pdf"},{"issue":"1","key":"e_1_3_6_23_1","first-page":"205521732110015","article-title":"Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy","volume":"7","author":"Almouzain L","year":"2021","unstructured":"Almouzain L , StevensonF, ChardD, RahmanNA, HamiltonF. Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy. Mult. Scler. J. Exp. Transl. Clin., 7(1), 20552173211001571 (2021).","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-019-00160-9"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419837809"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44750"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03794.x"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000453333"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-014-1960-9"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2014.04.003"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-5996-y"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh152"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012084"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70200-X"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000345970.73354.17"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70226-1"}],"container-title":["Neurodegenerative Disease Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/nmt-2022-0032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:48:32Z","timestamp":1716493712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/nmt-2022-0032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.2217\/nmt-2022-0032"],"URL":"https:\/\/doi.org\/10.2217\/nmt-2022-0032","relation":{},"ISSN":["1758-2024","1758-2032"],"issn-type":[{"value":"1758-2024","type":"print"},{"value":"1758-2032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}